WO2014202624A9 - Rasamsonia gene and use thereof - Google Patents

Rasamsonia gene and use thereof Download PDF

Info

Publication number
WO2014202624A9
WO2014202624A9 PCT/EP2014/062746 EP2014062746W WO2014202624A9 WO 2014202624 A9 WO2014202624 A9 WO 2014202624A9 EP 2014062746 W EP2014062746 W EP 2014062746W WO 2014202624 A9 WO2014202624 A9 WO 2014202624A9
Authority
WO
WIPO (PCT)
Prior art keywords
rasamsonia
gene
rasamsonia gene
Prior art date
Application number
PCT/EP2014/062746
Other languages
French (fr)
Other versions
WO2014202624A2 (en
Inventor
Alrik Pieter Los
Sacha DALHUIJSEN
Stefanus Cornelis Hendrikus Jozef Turk
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2014202624A2 publication Critical patent/WO2014202624A2/en
Publication of WO2014202624A9 publication Critical patent/WO2014202624A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
PCT/EP2014/062746 2013-06-19 2014-06-17 Rasamsonia gene and use thereof WO2014202624A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP13172736 2013-06-19
EP13172742 2013-06-19
EP13172612.7 2013-06-19
EP13172742.2 2013-06-19
EP13172733 2013-06-19
EP13172736.4 2013-06-19
EP13172733.1 2013-06-19
EP13172612 2013-06-19

Publications (2)

Publication Number Publication Date
WO2014202624A2 WO2014202624A2 (en) 2014-12-24
WO2014202624A9 true WO2014202624A9 (en) 2015-02-19

Family

ID=50943330

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/062746 WO2014202624A2 (en) 2013-06-19 2014-06-17 Rasamsonia gene and use thereof

Country Status (1)

Country Link
WO (1) WO2014202624A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754435B (en) * 2016-12-28 2020-04-21 江南大学 Construction method and application of recombinant mold with increased citric acid yield
BR112022010434A2 (en) 2019-11-29 2022-10-11 Lallemand Hungary Liquidity Man Llc YEAST EXPRESSING HETEROLOGOUS GLUCOAMYLASE

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (en) 1986-03-17 1986-03-17 Novo Industri As PREPARATION OF PROTEINS
FR2679920A1 (en) 1991-08-02 1993-02-05 Rhone Poulenc Rorer Sa Highly stable recombinant yeasts for the production of recombinant proteins, their preparation and their use
EP1321523A3 (en) 1993-07-23 2004-03-03 DSM IP Assets B.V. Selection marker gene free recombinant strains; a method for obtaining them and the use of these strains
DE69534185T2 (en) 1994-06-30 2006-02-23 Novozymes Biotech, Inc., Davis NON-TOXIC, NON-TOXIGEN, NON-PATHOGENIC FUSARIUM EXPRESSION SYSTEM, AND PROMOTERS AND TERMINATORS TO BE USED IN IT
CN1127571C (en) 1997-02-20 2003-11-12 Dsm公司 Fermentative production of valuable compounds on industrial scale using chemically defined media
EP2298913A1 (en) 1997-04-11 2011-03-23 DSM IP Assets B.V. Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
DE69838106T2 (en) 1997-12-22 2008-04-03 Dsm Ip Assets B.V. EXPRESSION CLONING IN FILAMENTOUS MUSHROOMS
CN100532561C (en) 1999-03-22 2009-08-26 诺沃奇梅兹有限公司 New glucoamylase and nucleic acid sequence coding same
WO2001021779A2 (en) 1999-09-17 2001-03-29 Dsm N.V. Penicillium chrysogenum transcriptional activator blar, a pathway specific regulator of beta-lactam biosynthesis, and uses therof
FR2826470B1 (en) 2001-06-26 2003-09-19 Astrium Sas METHOD AND DEVICE FOR STEERING THE ATTITUDE AND GUIDANCE OF A SATELLITE BY A GYRODYNES CLUSTER
AU2002333269A1 (en) 2001-07-23 2003-02-17 Dsm Ip Assets B.V. Process for preparing variant polynucleotides
AU2003303934A1 (en) 2002-05-30 2004-09-09 Dsm Ip Assets B.V. Novel pectinases and uses thereof
ES2294958B1 (en) 2003-07-15 2009-02-16 Mintek OXIDATIVE LIXIVIATION PROCEDURE.
AU2004272629A1 (en) 2003-09-12 2005-03-24 Commonwealth Scientific And Industrial Research Organisation Modified gene-silencing nucleic acid molecules and uses thereof
WO2005059149A2 (en) 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
DE602005023427D1 (en) 2004-04-02 2010-10-21 Dsm Ip Assets Bv FILAMENTOUS MUSHROOM MUTANES WITH IMPROVED HOMOLOGICAL RECOMBINATION EFFICIENCY
US8211667B2 (en) 2004-04-16 2012-07-03 Dsm Ip Assets B.V. Fungal promoter for expressing a gene in a fungal cell
DK1756145T3 (en) 2004-06-16 2014-09-29 Dsm Ip Assets Bv PRODUCTION OF POLYPEPTIDES THROUGH IMPROVED SECRETION
EP1799827A2 (en) 2004-10-12 2007-06-27 DSMIP Assets B.V. Fungal transcriptional activators useful in methods for producing a polypeptide
AU2006207463B2 (en) 2005-01-24 2011-03-17 Dsm Ip Assets B.V. Method for producing a compound of interest in a filamentous fungal cell
EP1856263A1 (en) 2005-03-01 2007-11-21 DSMIP Assets B.V. Aspergillus promotors for expressing a gene in a fungal cell
WO2007115886A1 (en) 2006-04-08 2007-10-18 Dsm Ip Assets B.V. Improved method for homologous recombination in eukaryotic cells
WO2008053019A2 (en) 2006-11-02 2008-05-08 Dsm Ip Assets B.V. Method for reducing the expression of a gene in a filamentous fungal cell
WO2008098933A1 (en) 2007-02-15 2008-08-21 Dsm Ip Assets B.V. A recombinant host cell for the production of a compound of interest
EP2126100B1 (en) 2007-03-21 2012-11-14 DSM IP Assets B.V. Improved method for homologous recombination
CN102066563A (en) 2008-06-11 2011-05-18 帝斯曼知识产权资产管理有限公司 Multi-species polynucleotide control sequences
EP2449087A1 (en) 2009-07-03 2012-05-09 DSM IP Assets B.V. Talaromyces strains and enzyme compositions
CN102597241B (en) 2009-07-22 2015-09-02 帝斯曼知识产权资产管理有限公司 For the production of the host cell through improving of interested compound
EP2955221A1 (en) 2009-11-04 2015-12-16 DSM IP Assets B.V. Talaromyces transformants
AU2011214324B2 (en) 2010-02-11 2014-11-20 Dsm Ip Assets B.V. Host cell capable of producing enzymes useful for degradation of lignocellulosic material
EA201300074A1 (en) 2010-07-01 2013-06-28 ДСМ АйПи АССЕТС Б.В. METHOD OF OBTAINING A REPRESENTATIVE INTEREST OF CONNECTION
JP5764016B2 (en) 2011-09-07 2015-08-12 日東電工株式会社 CIGS film manufacturing method and CIGS solar cell manufacturing method using the same

Also Published As

Publication number Publication date
WO2014202624A2 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
EP3039174A4 (en) Oligonucleotide probes and uses thereof
EP3708210B8 (en) Patient interface and aspects thereof
EP3043784A4 (en) Aryl ethers and uses thereof
EP3087059A4 (en) Indazoles and use thereof
EP3030566A4 (en) Aza-pyridone compounds and uses thereof
EP3046932A4 (en) Evolved sortases and uses thereof
EP3049086A4 (en) Irak inhibitors and uses thereof
EP3003390A4 (en) Anti-c10orf54 antibodies and uses thereof
EP3075735A4 (en) Glycolurils having functional group and use thereof
EP2959020A4 (en) Rare clonotypes and uses thereof
EP3060561A4 (en) Strigolactone formulations and uses thereof
EP3083606A4 (en) Pyrimidines and use thereof
EP3052515A4 (en) Anti-alphavbeta1 integrin compounds and methods
EP2968503A4 (en) Anti-hepcidin antibodies and uses thereof
EP3038458A4 (en) Sowing unit and uses thereof
EP3075847A4 (en) Transaminase and use thereof
PL3536804T3 (en) Micropeptides and use thereof for modulating gene expression
EP3081644A4 (en) Modified lipase and use thereof
EP3048108A4 (en) Thienopiperidine derivative and use thereof
EP3017225A4 (en) Bracket and use
EP3042689A4 (en) Syringe and syringe set
EP3060682A4 (en) Genetic markers and uses therefor
EP3041891A4 (en) Materials and methods
HK1231503A1 (en) Gene mutant and application thereof
EP3059304A4 (en) Novel microorganism and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14730552

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14730552

Country of ref document: EP

Kind code of ref document: A2